Table 2.
Effect of the cGMP-specific PDE (PDE5) inhibitor, zaprinast, on the generation of histamine, IL-13 and IL-4 from basophils activated with IL-3

Effect of the cGMP-specific PDE (PDE5) inhibitor, zaprinast, on the generation of histamine, IL-13 and IL-4 from basophils activated with IL-3
